FDA Inspection 1237587 - Avista Pharma Solutions, Inc. dba Cambrex - May 03, 2024

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Avista Pharma Solutions, Inc. dba Cambrex

Record Details

This FDA Inspection record concerns Avista Pharma Solutions, Inc. dba Cambrex, with an inspection on May 3, 2024, issued by the Center for Drug Evaluation and Research.

Company: Avista Pharma Solutions, Inc. dba Cambrex
Inspection Date: May 3, 2024
Office: Center for Drug Evaluation and Research

Open in Dashboard

ID · 0b0b6fab-e480-4edd-95fe-6c322c0023e9

Violation Codes4

21 CFR 211.160(b)21 CFR 211.194(d)21 CFR 211.22(d)21 CFR 211.25(a)

Full citation text and observation details available on the Dashboard.